Correlation Between Elutia and Vivos Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elutia and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elutia and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elutia Inc and Vivos Therapeutics, you can compare the effects of market volatilities on Elutia and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elutia with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elutia and Vivos Therapeutics.

Diversification Opportunities for Elutia and Vivos Therapeutics

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Elutia and Vivos is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Elutia Inc and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and Elutia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elutia Inc are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of Elutia i.e., Elutia and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between Elutia and Vivos Therapeutics

Given the investment horizon of 90 days Elutia Inc is expected to under-perform the Vivos Therapeutics. In addition to that, Elutia is 1.1 times more volatile than Vivos Therapeutics. It trades about -0.08 of its total potential returns per unit of risk. Vivos Therapeutics is currently generating about 0.61 per unit of volatility. If you would invest  283.00  in Vivos Therapeutics on September 20, 2024 and sell it today you would earn a total of  207.00  from holding Vivos Therapeutics or generate 73.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Elutia Inc  vs.  Vivos Therapeutics

 Performance 
       Timeline  
Elutia Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Elutia Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Elutia is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Vivos Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Elutia and Vivos Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elutia and Vivos Therapeutics

The main advantage of trading using opposite Elutia and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elutia position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.
The idea behind Elutia Inc and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk